117 related articles for article (PubMed ID: 33256644)
1. An assessment of the potential miscalibration of cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in England.
Pate A; van Staa T; Emsley R
BMC Med Res Methodol; 2020 Nov; 20(1):289. PubMed ID: 33256644
[TBL] [Abstract][Full Text] [Related]
2. The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care.
Pate A; Emsley R; Ashcroft DM; Brown B; van Staa T
BMC Med; 2019 Jul; 17(1):134. PubMed ID: 31311543
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment.
Xu Z; Arnold M; Stevens D; Kaptoge S; Pennells L; Sweeting MJ; Barrett J; Di Angelantonio E; Wood AM
Am J Epidemiol; 2021 Oct; 190(10):2000-2014. PubMed ID: 33595074
[TBL] [Abstract][Full Text] [Related]
4. Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study.
Livingstone SJ; Guthrie B; Donnan PT; Thompson A; Morales DR
BMC Med; 2022 May; 20(1):152. PubMed ID: 35505353
[TBL] [Abstract][Full Text] [Related]
5. An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions.
Robinson T; Jackson R; Wells S; Kerr A; Marshall R
N Z Med J; 2017 Oct; 130(1463):28-38. PubMed ID: 28981492
[TBL] [Abstract][Full Text] [Related]
6. Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care.
Pate A; Emsley R; van Staa T
Br J Gen Pract; 2020 Nov; 70(700):e765-e771. PubMed ID: 33020170
[TBL] [Abstract][Full Text] [Related]
7. Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease.
Akyea RK; Kai J; Qureshi N; Iyen B; Weng SF
Heart; 2019 Jul; 105(13):975-981. PubMed ID: 30988003
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses.
Garg N; Muduli SK; Kapoor A; Tewari S; Kumar S; Khanna R; Goel PK
Indian Heart J; 2017; 69(4):458-463. PubMed ID: 28822511
[TBL] [Abstract][Full Text] [Related]
9. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
10. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
Perera R; McFadden E; McLellan J; Lung T; Clarke P; Pérez T; Fanshawe T; Dalton A; Farmer A; Glasziou P; Takahashi O; Stevens J; Irwig L; Hirst J; Stevens S; Leslie A; Ohde S; Deshpande G; Urayama K; Shine B; Stevens R
Health Technol Assess; 2015 Dec; 19(100):1-401, vii-viii. PubMed ID: 26680162
[TBL] [Abstract][Full Text] [Related]
11. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
12. Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.
Andersson C; Enserro D; Larson MG; Xanthakis V; Vasan RS
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25888372
[TBL] [Abstract][Full Text] [Related]
13. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
Ramos R; Comas-Cufí M; Martí-Lluch R; Balló E; Ponjoan A; Alves-Cabratosa L; Blanch J; Marrugat J; Elosua R; Grau M; Elosua-Bayes M; García-Ortiz L; Garcia-Gil M
BMJ; 2018 Sep; 362():k3359. PubMed ID: 30185425
[TBL] [Abstract][Full Text] [Related]
14. Relation of Absence of Coronary Artery Calcium to Cardiovascular Disease Mortality Risk Among Individuals Meeting Criteria for Statin Therapy According to the 2018/2019 ACC/AHA Guidelines.
Rajan T; Rozanski A; Cainzos-Achirica M; Grandhi GR; Dardari ZA; Al-Mallah MH; Blankstein R; Miedema MD; Shaw LJ; Rumberger JA; Budoff MJ; Blaha MJ; Berman D; Nasir K
Am J Cardiol; 2020 Dec; 136():49-55. PubMed ID: 32941817
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
16. Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011.
Ou HT; Chang KC; Li CY; Yang CY; Ko NY
Int J Cardiol; 2017 Mar; 230():592-598. PubMed ID: 28062146
[TBL] [Abstract][Full Text] [Related]
17. The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented.
Pate A; Elliott RA; Gkountouras G; Thompson A; Emsley R; van Staa T
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):644-652. PubMed ID: 32394495
[TBL] [Abstract][Full Text] [Related]
18. Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar.
Li Y; Sperrin M; Ashcroft DM; van Staa TP
BMJ; 2020 Nov; 371():m3919. PubMed ID: 33148619
[TBL] [Abstract][Full Text] [Related]
19. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
